Literature DB >> 27933338

Progress in Research and Application of HIV-1 TAT-Derived Cell-Penetrating Peptide.

Le Zou1, Qilin Peng1, Ping Wang1,2, Boting Zhou3,4.   

Abstract

Human immunodeficiency virus type I (HIV-1) transactivator of transcription (TAT) is encoded by HIV-1. It is a peptide rich in basic amino acids and belongs to the protein transduction domain family. It has been found that HIV-1 TAT and its core peptide segment TAT47-57 play an important role in promoting the cellular uptake of coupled bioactive macromolecules, such as peptides, proteins, oligonucleotides, and drug molecules. HIV-1 TAT can also significantly increase the soluble expression of extrinsic proteins. However, the mechanism behind the cellular uptake of HIV-1 TAT-derived cell-penetrating peptide remains unclear. This review focuses on the research into HIV-1 TAT-derived cell-penetrating peptide over the last years. We briefly discuss TAT's structural features, functions and applications, the mechanism of its cellular internalization, current challenges, and their possible solutions. At the end of this review, we provide a summary and predict the future research directions and potential applications of HIV-1 TAT when it is used as a cell-penetrating peptide.

Entities:  

Keywords:  Application; Cell-penetrating peptide; Endocytosis; HIV-1 TAT; Internalization; Mechanism

Mesh:

Substances:

Year:  2016        PMID: 27933338     DOI: 10.1007/s00232-016-9940-z

Source DB:  PubMed          Journal:  J Membr Biol        ISSN: 0022-2631            Impact factor:   1.843


  51 in total

1.  Studies on the internalization mechanism of cationic cell-penetrating peptides.

Authors:  Guillaume Drin; Sylvine Cottin; Emmanuelle Blanc; Anthony R Rees; Jamal Temsamani
Journal:  J Biol Chem       Date:  2003-06-03       Impact factor: 5.157

2.  OVCAR-3 cells internalize TAT-peptide modified liposomes by endocytosis.

Authors:  Marjan M Fretz; Gerben A Koning; Enrico Mastrobattista; Wim Jiskoot; Gert Storm
Journal:  Biochim Biophys Acta       Date:  2004-10-11

3.  siRNA and pharmacological inhibition of endocytic pathways to characterize the differential role of macropinocytosis and the actin cytoskeleton on cellular uptake of dextran and cationic cell penetrating peptides octaarginine (R8) and HIV-Tat.

Authors:  M Al Soraj; L He; K Peynshaert; J Cousaert; D Vercauteren; K Braeckmans; S C De Smedt; A T Jones
Journal:  J Control Release       Date:  2012-03-24       Impact factor: 9.776

4.  Cellular internalization of fluorescent proteins via arginine-rich intracellular delivery peptide in plant cells.

Authors:  Microsugar Chang; Jyh-Ching Chou; Han-Jung Lee
Journal:  Plant Cell Physiol       Date:  2005-02-02       Impact factor: 4.927

5.  Rapid and effective labeling of brain tissue using TAT-conjugated CdS:Mn/ZnS quantum dots.

Authors:  Swadeshmukul Santra; Heesun Yang; Jessie T Stanley; Paul H Holloway; Brij M Moudgil; Glenn Walter; Robert A Mericle
Journal:  Chem Commun (Camb)       Date:  2005-05-19       Impact factor: 6.222

6.  The trans-activator gene of HTLV-III is essential for virus replication.

Authors:  A G Fisher; M B Feinberg; S F Josephs; M E Harper; L M Marselle; G Reyes; M A Gonda; A Aldovini; C Debouk; R C Gallo
Journal:  Nature       Date:  1986 Mar 27-Apr 2       Impact factor: 49.962

7.  The third helix of the Antennapedia homeodomain translocates through biological membranes.

Authors:  D Derossi; A H Joliot; G Chassaing; A Prochiantz
Journal:  J Biol Chem       Date:  1994-04-08       Impact factor: 5.157

8.  Cellular uptake of unconjugated TAT peptide involves clathrin-dependent endocytosis and heparan sulfate receptors.

Authors:  Jean Philippe Richard; Kamran Melikov; Hilary Brooks; Paul Prevot; Bernard Lebleu; Leonid V Chernomordik
Journal:  J Biol Chem       Date:  2005-02-01       Impact factor: 5.157

9.  Dominant cytotoxic T lymphocyte response to the immediate-early trans-activator protein, BZLF1, in persistent type A or B Epstein-Barr virus infection.

Authors:  S L Elliott; S J Pye; C Schmidt; S M Cross; S L Silins; I S Misko
Journal:  J Infect Dis       Date:  1997-10       Impact factor: 5.226

10.  In Vivo Delivery of a Bcl-xL Fusion Protein Containing the TAT Protein Transduction Domain Protects against Ischemic Brain Injury and Neuronal Apoptosis.

Authors:  Guodong Cao; Wei Pei; Hailiang Ge; Qinhua Liang; Yumin Luo; Frank R Sharp; Aigang Lu; Ruiqiong Ran; Steven H Graham; Jun Chen
Journal:  J Neurosci       Date:  2002-07-01       Impact factor: 6.167

View more
  12 in total

1.  Genetic transformation of Chlorella vulgaris mediated by HIV-TAT peptide.

Authors:  Pavan Gadamchetty; Phanindra Lakshmi Venkata Mullapudi; Raghavendrarao Sanagala; Manickavasagam Markandan; Ananda Kumar Polumetla
Journal:  3 Biotech       Date:  2019-03-13       Impact factor: 2.406

2.  Absolute Quantification of Drug Vector Delivery to the Cytosol.

Authors:  Marco Lucchino; Anne Billet; Siau-Kun Bai; Estelle Dransart; Justine Hadjerci; Frédéric Schmidt; Christian Wunder; Ludger Johannes
Journal:  Angew Chem Int Ed Engl       Date:  2021-05-28       Impact factor: 15.336

3.  TAT-modified serum albumin nanoparticles for sustained-release of tetramethylpyrazine and improved targeting to spinal cord injury.

Authors:  Yan Lin; Yujie Wan; Xingjie Du; Jian Li; Jun Wei; Ting Li; Chunhong Li; Zhongbing Liu; Meiling Zhou; Zhirong Zhong
Journal:  J Nanobiotechnology       Date:  2021-01-21       Impact factor: 10.435

4.  Evaluation of the Antiviral Activity of Sitagliptin-Glatiramer Acetate Nano-Conjugates against SARS-CoV-2 Virus.

Authors:  Nabil A Alhakamy; Osama A A Ahmed; Tarek S Ibrahim; Hibah M Aldawsari; Khalid Eljaaly; Usama A Fahmy; Ahmed L Alaofi; Filippo Caraci; Giuseppe Caruso
Journal:  Pharmaceuticals (Basel)       Date:  2021-02-24

Review 5.  Discovery of Antivirals Using Phage Display.

Authors:  Esen Sokullu; Marie-Soleil Gauthier; Benoit Coulombe
Journal:  Viruses       Date:  2021-06-10       Impact factor: 5.048

6.  TAT-dextran-mediated mitochondrial transfer enhances recovery from models of reperfusion injury in cultured cardiomyocytes.

Authors:  Hideki Maeda; Daisuke Kami; Ryotaro Maeda; Yuki Murata; Jun-Ichiro Jo; Tomoya Kitani; Yasuhiko Tabata; Satoaki Matoba; Satoshi Gojo
Journal:  J Cell Mol Med       Date:  2020-03-25       Impact factor: 5.310

7.  Optimized Conjugation of Fluvastatin to HIV-1 TAT Displays Enhanced Pro-Apoptotic Activity in HepG2 Cells.

Authors:  Lamya H Al-Wahaibi; Muneera S M Al-Saleem; Osama A A Ahmed; Usama A Fahmy; Nabil A Alhakamy; Basma G Eid; Ashraf B Abdel-Naim; Wael M Abdel-Mageed; Maha M AlRasheed; Gamal A Shazly
Journal:  Int J Mol Sci       Date:  2020-06-10       Impact factor: 5.923

Review 8.  The peptide PROTAC modality: a novel strategy for targeted protein ubiquitination.

Authors:  Jinmei Jin; Ye Wu; Jinjiao Chen; Yiwen Shen; Lijun Zhang; Hong Zhang; Lili Chen; Hebao Yuan; Hongzhuan Chen; Weidong Zhang; Xin Luan
Journal:  Theranostics       Date:  2020-08-08       Impact factor: 11.556

9.  Inactivation of HIV-1 in Polarized Infant Tonsil Epithelial Cells by Human Beta-Defensins 2 and 3 Tagged with the Protein Transduction Domain of HIV-1 Tat.

Authors:  Rossana Herrera; Kristina Rosbe; Sharof M Tugizov
Journal:  Viruses       Date:  2021-10-11       Impact factor: 5.048

10.  De Novo Design of Peptidic Positive Allosteric Modulators Targeting TRPV1 with Analgesic Effects.

Authors:  Lizhen Xu; Heng Zhang; Yunfei Wang; Xiancui Lu; Zhenye Zhao; Cheng Ma; Shilong Yang; Vladimir Yarov-Yarovoy; Yuhua Tian; Jie Zheng; Fan Yang
Journal:  Adv Sci (Weinh)       Date:  2021-07-11       Impact factor: 16.806

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.